|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61K 39/39558 | (2013.01) | ||
| C07K 16/28 | (2006.01) | ||
| A61K2039/505 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K2039/55 | (2013.01) | ||
| A61K2039/804 | (2018.08) | ||
| C07K 16/2887 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K2039/545 | (2013.01) | ||
| C07K 16/2803 | (2013.01) | ||
| A61K2039/507 | (2013.01) |
| (11) | Number of the document | 4129336 |
| (13) | Kind of document | T |
| (96) | European patent application number | 22183160.5 |
| Date of filing the European patent application | 2019-02-11 | |
| (97) | Date of publication of the European application | 2023-02-08 |
| (45) | Date of publication and mention of the grant of the patent | 2025-05-07 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201862629340 P | 2018-02-12 | US | |
| 201862678468 P | 2018-05-31 | US | |
| 201862743060 P | 2018-10-09 | US | |
| 201862743875 P | 2018-10-10 | US |
| (72) |
CHAO, Mark Ping , US
TAKIMOTO, Chris Hidemi Mizufune , US
VOLKMER, Jens-Peter , US
|
| (73) |
Forty Seven, LLC ,
333 Lakeside Drive, Foster City, CA 94404,
US
|
| (54) | ANTI-CD47 AGENT-BASED TREATMENT OF CD20-POSITIVE CANCER |
| ANTI-CD47 AGENT-BASED TREATMENT OF CD20-POSITIVE CANCER |